Riskpilot← Back to searchSign inGet full accessPerimed Aktiebolag
ABActiveOrg 5561966903Datavägen 9 AManufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 197842 employees
Revenue 2024
SEK 68,9M
-20% vs 2023
EBITDA margin
-31.3%
-43% vs 2023
Equity ratio
69.6%
Financial strength
Net profit 2024
SEK -29M
-158% vs 2023
| Revenue | SEK 68,9M | -20% |
| EBITDA | SEK -21,5M | -43% |
| Net profit | SEK -29M | -158% |
| Total assets | SEK 73M | +13% |
| Equity | SEK 50,8M | +4228% |
| Employees | 42 | — |
Legal name
Perimed Aktiebolag
Org number
5561966903
Legal form
Aktiebolag
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
22 mars 1978
Share capital
SEK 3 088 000
Employees
42 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Bakken, Björn i förening med en av Bodd, Michael Mariero, Lars Henrik Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall utveckla, tillverka, sälja och hyra ut diagnostisk och terapeutisk apparatur för medicinsk forskning och sjukvård, samt utöva därmed förenlig verksamt. Bolaget ska dessutom handla med värdepapper samt förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Datavägen 9 A
Phone
+46858011990
Email
mail@perimed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 72 987 | 77 530 | 85 243 | 86 455 | 68 855 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 7 587 | −334 | 554 | −15 077 | −21 537 |
| Depreciation & amort. | −781 | −3 019 | −4 172 | −6 173 | −7 625 |
| EBIT | 6 806 | −3 353 | −3 618 | −21 250 | −29 162 |
| Net financials | −202 | −191 | −401 | 10 029 | 182 |
| Profit before tax | 6 604 | −3 545 | −4 019 | −11 218 | −28 980 |
| Tax | −0 | −0 | −0 | −40 | −29 |
| Net profit | 6 604 | −3 545 | −4 019 | −11 258 | −29 009 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 51 817 | 62 667 | 67 477 | 64 486 | 73 004 |
| Equity | 17 497 | 15 352 | 12 432 | 1 174 | 50 814 |
| Long-term debt | 14 540 | 12 940 | 11 340 | 9 740 | 0 |
| Short-term debt | 19 781 | 34 329 | 43 544 | 53 298 | 21 802 |
| Total debt | 34 321 | 47 269 | 54 884 | 63 038 | 21 802 |
EBITDA margin
-31.3%
This company
15.8%
Market median
-298% vs market
20202024
Equity ratio
69.6%
This company
38.2%
Market median
+82% vs market
20202024
Return on equity
-57.1%
This company
18.4%
Market median
-410% vs market
20202024
Net profit margin
-42.1%
This company
8.1%
Market median
-620% vs market
20202024
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
20202024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
HA Chief Executive Officer | Chief Executive Officer | 2024 |
EK Chief Auditor | Chief Auditor | 2024 |
PA Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (3) | ||
ML Chief Auditor | Chief Auditor | 2021 – 2024 |
CE Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
LM Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2024 | |
| Former (6) | ||
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2025 – 2025 | |
| Chairman | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Björn Bakken Holding AB
Perimed Aktiebolag (this company)Perimed Italia SrlPERIMED ITALIA SRLPerimed Uk LtdPerimed IncPerimed Instruments GmbhPerimed France SarlPerimed Nederland BvPerimed Hong Kong LtdPERIMED HONG KONG LTDPERIMED INSTRUMENTS GMBHPERIMED INCPERIMED UK LTDPERIMED FRANCE SARLPERIMED NEDERLAND BVBoard members of Perimed Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Lennart Blomgren | Chief Auditor | 0 companies |
| Hans-Eric Aaltonen | Chief Executive Officer | 0 companies |
| Emma Kristina Nelson Stavefeldt | Chief Auditor | 0 companies |
| Per Anders Wallén | Chief Executive Officer | 0 companies |
| Charlotte Eva Catrin Molund | Chief Executive Officer | 0 companies |
| Lena Maria Åredal | Chief Executive Officer | 0 companies |
| Lars Henrik Mariero | Board of Directors | 0 companies |
| Ulrika Maria Hellman | Board of Directors | 0 companies |
| Lars Magnus Verner Ling | Board of Directors | 0 companies |
| Andreas Filip A Ringman Uggla | Board of Directors | 0 companies |
| Mats Bertil Fischier | Board of Directors | 0 companies |
| Jan Peter Troija | Board of Directors | 0 companies |
| Synne Hermansen Røine | Deputy Board Member | 0 companies |
| Katherine Wang | Deputy Board Member | 0 companies |
| Carl Göran Torkel Elgh | Chairman | 0 companies |
| Michael Bodd | Board of Directors | 0 companies |
| Björn Bakken | Chairman | 0 companies |